$MNOV

$2.63▲ -6.4% YTD

2 SEC 13D/G filings tracked · Last updated Sep 24, 2026

Filing History

CP $2.63▲ -6.4%Sep 24, 2026 · ThinkSabio Blog

$MNOV Announces Completion of Last Patient, Last Visit in the Double-Blind Portion of the Phase 2b/3 COMBAT-ALS Trial of MN-166 (Ibudilast) Topline da…

News

MNOV ▼ -6.4% - MediciNova, Inc.

CP $2.63▲ -6.4%Sep 24, 2026 · ThinkSabio Blog

$MNOV - MediciNova Announces Completion of Last Patient, Last Visit in the Double-Blind Portion of the Phase 2b/3 COMBAT-ALS Trial of MN-166 (Ibudilas…